Kinsing Ko

Kinsing Ko


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2020 in Open Heart
Verified
Journal Article
Open access
PDF file
KKKinsing Ko
Kinsing Ko
TKThom L de Kroon
Thom L de Kroon
MPMarco C Post
Marco C Post
JKJohannes C Kelder
Johannes C Kelder
KSKaren F Schut
Karen F Schut
BPBart P van Putte
Bart P van Putte
Objective: Minimally invasive surgery is increasingly adopted as an alternative to conventional sternotomy for mitral valve pathology in many centres worldwide. A systematic safety analysis based on a comprehensive list of pre-specified 30-day complications defined by the Mitral Valve Academic Consortium (MVARC) criteria is lacking. The aim of the current study was to systematically analyse the safety of minimally invasive mitral valve surgery in our centre based on the MVARC definitions. Methods: All consecutive patients undergoing minimally invasive mitral valve surgery through right mini-thoracotomy in our institution within 10 years were studied retrospectively. The primary outcome was a composite of 30-day major complications based on MVARC definitions. Results: 745 patients underwent minimally invasive mitral valve surgery (507 repair, 238 replacement), with a mean age of 62.9±12.3 years. The repair was successful in 95.8%. Overall 30-day mortality was 1.2% and stroke rate 0.3%. Freedom from any 30-day major complications was 87.2%, and independent predictors were left ventricular ejection fraction <50% (OR 1.78; 95% CI 1.02 to 3.02) and estimated glomerular filtration rate <60 mL/min/1.73 m2 (OR 1.98; 95% CI 1.17 to 3.26). Conclusions: Minimally invasive mitral valve surgery is a safe technique and is associated with low 30-day mortality and stroke rate.

1 January 2022 in Journal of Invasive Cardiology
Verified
Journal Article
Closed access
KKKinsing Ko
Kinsing Ko
PZPetrus Zwetsloot
Petrus Zwetsloot
MVMD Michiel Voskuil
MD Michiel Voskuil
PSPieter Stella
Pieter Stella
TLTim Leiner
Tim Leiner
AKAdriaan Kraaijeveld
Adriaan Kraaijeveld
A systematic search on Medline, Embase, and Cochrane resulted in 19 retrospective studies (published from 2010-2020) reporting SIFs in the work-up for TAVI.

11 October 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KKKinsing Ko
Kinsing Ko
AVAd F.T.M. Verhagen
Ad F.T.M. Verhagen
TKthomas de kroon
thomas de kroon
WMWim J. Morshuis
Wim J. Morshuis
LGLeen A. F. M. van Garsse
Leen A. F. M. van Garsse
Minimally invasive mitral valve surgery is evolving rapidly since the early 1990’s and is now increasingly adopted as the standard approach for mitral valve surgery. It has a long and challenging learning curve and there are many considerations regarding technique, planning and patient selection when starting a minimally invasive program. In the current review, we provide an overview of all considerations and the decision-making process during the learning curve.

1 January 2022 in Seminars in Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
KKKinsing Ko
Kinsing Ko
TKThom L. de Kroon
Thom L. de Kroon
JKJohannes C. Kelder
Johannes C. Kelder
NSNabil Saouti
Nabil Saouti
BPBart P. van Putte
Bart P. van Putte

1 January 2023 in Seminars in Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
KKKinsing Ko
Kinsing Ko
TKThom L. de Kroon
Thom L. de Kroon
KSKaren F. Schut
Karen F. Schut
JKJohannes C. Kelder
Johannes C. Kelder
NSNabil Saouti
Nabil Saouti
BPBart P. van Putte
Bart P. van Putte

28 January 2026 in Interdisciplinary CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
ATAndrew Tjon Joek Tjien
Andrew Tjon Joek Tjien
KKKinsing Ko
Kinsing Ko
SHSam Heuts
Sam Heuts
SHSaskia Houterman
Saskia Houterman
MRMaaike Roefs
Maaike Roefs
CRCardiothoracic Surgery Registration Committee of the NetherlandsHeart Registration
Cardiothoracic Surgery Registration Committee of the NetherlandsHeart Registration
Objectives: Older patients are more prone to postoperative morbidity and mortality after mitral valve (MV) surgery. Minimally invasive MV surgery (MIMVS) is increasingly adopted worldwide, with a potential benefit in the elderly. This study compares short-term and mid-term outcomes in patients above 70 years, undergoing MIMVS versus median sternotomy (MST), in a nationwide registry. Methods: All patients above 70 years undergoing primary elective MV surgery (±tricuspid valve [TV] surgery, atrial septal defect closure, rhythm surgery) between 2013 and 2021 were included. All data were extracted from the Netherlands Heart Registration. Primary outcomes were short-term morbidity, mortality, and 5-year survival. Results: In total, 1418 patients were included (MST n = 797, MIMVS n = 621). No statistically significant differences in baseline characteristics were found. Median Logistic EuroSCORE I was 6.3 [4.7–8.5] vs 6.0 [4.6–8.5], P = .27 for MST and MIMVS, respectively. Mitral valve repair (77.7% vs 64.7% P < .001) and concomitant TV surgery (43.9% vs 18.2%, P < .001) was more frequently performed in MST. Lower 30-day mortality was observed in MIMVS (0.6% [n = 4] vs 2.5% [n = 21], P = .01). Furthermore, the incidence of pneumonia, prolonged intubation, readmission to intensive care unit, kidney failure, and new-onset arrhythmia were lower for MIMVS. No difference in 5-year survival was found (MST: 89.1 ± 4.6% vs MIMVS: 91.6 ± 4.7% Log-Rank P = .51). Conclusions: Minimally invasive MV surgery in patients above 70 years may be associated with lower 30-day mortality and incidence of postoperative complications compared with sternotomy.